Source:http://linkedlifedata.com/resource/pubmed/id/19083093
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2009-4-7
|
pubmed:abstractText |
We examined whether a nitric oxide scavenger, 2-(4-carboxyphenyl)-4,4,5,5-tetramethyl-imidazoline-L: -oxyl-3-oxide (carboxy-PTIO), could offer neuroprotective actions and improve cerebral energy metabolism in a model of stroke. Sixty C57BL/10J mice were given either carboxy-PTIO (0.3-1.2 mg/kg) or vehicle intraperitoneally, 0.5 h after permanent middle cerebral artery occlusion, to evaluate the dose-response effects. An additional 70 animals received carboxy-PTIO (0.6 mg/kg) or vehicle, 2-6 h post-ischemia, for establishing the therapeutic window. Subgroups of animals, treated with carboxy-PTIO (0.6 mg/kg) or vehicle, were used for measuring cerebral bioenergetic metabolites (ATP, ADP, AMP, adenosine). Mice treated with carboxy-PTIO (0.6 mg/kg) had dose-specifically reduced brain infarction, significantly by 27-30% (P < 0.05), even when therapy was delayed up to 4 h after the ischemic insult (P < 0.05). Four hour post-ischemia, ATP depleted in the ischemic hemisphere (P < 0.05). Administration with carboxy-PTIO not only improved the recovery of ATP in the ischemic hemisphere (P < 0.05), but also enhanced adenosine content across the ischemic and non-ischemic hemispheres (P < 0.05). The neuroprotection of carboxy-PTIO may be partly attributed to the beneficial effects of improving cerebral energy metabolism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1,3-dihydroxy-4,4,5,5-tetramethyl-2-...,
http://linkedlifedata.com/resource/pubmed/chemical/Benzoates,
http://linkedlifedata.com/resource/pubmed/chemical/Imidazoles,
http://linkedlifedata.com/resource/pubmed/chemical/Neuroprotective Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide Synthase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1573-6903
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
34
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1157-66
|
pubmed:meshHeading |
pubmed-meshheading:19083093-Animals,
pubmed-meshheading:19083093-Benzoates,
pubmed-meshheading:19083093-Body Temperature,
pubmed-meshheading:19083093-Brain,
pubmed-meshheading:19083093-Brain Infarction,
pubmed-meshheading:19083093-Brain Ischemia,
pubmed-meshheading:19083093-Cerebrovascular Circulation,
pubmed-meshheading:19083093-Dose-Response Relationship, Drug,
pubmed-meshheading:19083093-Energy Metabolism,
pubmed-meshheading:19083093-Imidazoles,
pubmed-meshheading:19083093-Male,
pubmed-meshheading:19083093-Mice,
pubmed-meshheading:19083093-Mice, Inbred C57BL,
pubmed-meshheading:19083093-Neuroprotective Agents,
pubmed-meshheading:19083093-Nitric Oxide,
pubmed-meshheading:19083093-Nitric Oxide Synthase,
pubmed-meshheading:19083093-Stroke
|
pubmed:year |
2009
|
pubmed:articleTitle |
Delayed treatment with carboxy-PTIO permits a 4-h therapeutic window of opportunity and prevents against ischemia-induced energy depletion following permanent focal cerebral ischemia in mice.
|
pubmed:affiliation |
Department of Surgery, National Cheng Kung University Hospital and Medical School, Tainan, Taiwan. ejian@mail.ncku.edu.tw
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|